ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Meet With NCI to Discuss Plan to use Rosenberg’s Regimen At Member Institutions

December 13, 1985

Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”.

April 7, 2006

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985